TachoSil对前列腺癌扩大盆腔淋巴结清扫后淋巴囊肿形成影响的前瞻性随机对照试验
该前瞻性随机对照试验纳入100例前列腺癌患者,随机分为双侧TachoSil放置组与对照组,比较淋巴囊肿发生率、体积及引流情况。
核心结论
- 双侧TachoSil放置可能减少术后早期影像学淋巴囊肿形成,但总体发生率无显著差异,临床意义存疑。
研究设计与样本
- 2013至2017年前瞻性随机对照试验,纳入100例拟行分期PLND后外照射放疗(n=50)或PLND联合根治性前列腺切除术(RP)(n=50)的前列腺癌患者,1:1随机分为双侧TachoSil放置组与未放置组。
主要发现
- TachoSil组与对照组患者、肿瘤及手术特征无显著差异。
- 其他术后特征在两组间无显著差异(单纯PLND及PLND+RP患者均如此)。
临床怎么用
- TachoSil可能用于减少PLND术后早期影像学淋巴囊肿,但需权衡其临床获益的不确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore whether TachoSil, a hemostatic patch, can reduce the incidence of lymphocele formation. Development of a lymphocele is a frequent complication after pelvic lymph node dissection (PLND) for nodal staging in prostate cancer. MATERIALS AND METHODS: From 2013 to 2017, 100 patients with prostate cancer who were set to undergo a staging PLND before external beam radiotherapy (n = 50) or PLND concomitant with radical prostatectomy (RP) (n = 50) were prospectively randomized 1:1 between bilateral TachoSil placement or nonplacement. Primary end points were radiographic lymphocele development, lymphocele volume (1 week and 1 month postoperatively), and the duration and volume of postoperative catheter drainage. RESULTS: Patient, tumor, and surgical characteristics of the TachoSil and the control groups did not differ significantly. In total, 65 patients (65%) experienced a radiographic lymphocele up to 3 months after surgery: 29 (58%) in the TachoSil group and 36 (72%) in the control group (P = .34). Significantly less radiographic lymphoceles were observed 1 week postoperatively for patients who underwent sole PLND and 1 month postoperatively for patients who underwent PLND with RP in the TachoSil group compared with the control group (16% vs 48%, P = .024, and 24% vs 52%, P = .047, respectively). The other postoperative characteristics presented no significant differences between the 2 groups, neither for patients undergoing sole PLND nor for patients undergoing PLND with RP. CONCLUSION: Patients undergoing bilateral TachoSil placement after PLND seem less likely to develop a radiographic lymphocele early postoperatively. Nevertheless, the clinical relevance of the use of TachoSil remains highly debatable.
引用
- Buelens S, Van Praet C, Poelaert F, et al. Prospective Randomized Controlled Trial Exploring the Effect of TachoSil on Lymphocele Formation After Extended Pelvic Lymph Node Dissection in Prostate Cancer. Urology. 2018. PMID: 29775698. doi:10.1016/j.urology.2018.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。